What question did this study set out to answer?

This study aimed to assess the toxicity of glucocorticoids in patients with systemic lupus erythematosus across varying dosage ranges.

May 1, 2026

Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.

View Full Paper

Ask AI

Bookmark

This study aimed to assess the toxicity of glucocorticoids in patients with systemic lupus erythematosus across varying dosage ranges.
Patients from the STAR cohort were followed for 1 year, stratified by average daily prednisone dose.
Toxicity was assessed using the glucocorticoid toxicity index, including aggregate improvement and cumulative worsening scores.
Three comparisons were made using dose thresholds of 7.5 mg, 5 mg, and 2.5 mg with statistical corrections applied.
Patients on prednisone ≤ 7.5 mg/day had lower median cumulative worsening scores (CWS) and aggregate improvement scores (AIS) compared to those on higher doses (P < 0.001).
Within the low-dose group, those with 5 < PDN ≤ 7.5 mg/day showed higher median CWS and wider AIS interquartile range than the ≤ 5 mg/day subgroup.
Quantile regression found that each 1 mg/day increase in prednisone dose raised median CWS by 3.33 points and median AIS by 3.42 points.

No takes yet. Share an insight, caveat, or question.

Randomized trial quantifies glucocorticoid toxicity in systemic lupus erythematosus, suggesting lower doses may reduce side effects.

Zhang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark